StreetInsider.com News Articles

Texas Capital Securities Downgrades Melco Resorts (MLCO) to Hold

Fri, 16 Oct 2026 04:31:12 -0400

Texas Capital Securities analyst David Bain downgraded Melco Resorts (NASDAQ: MLCO) from Buy to Hold with a price target of $5.50 (from $8.00).

The analyst comments: “We lower MLCO to Hold from Buy. Reasons for our rating downgrade include 1) A strong variance between our 3Q/4Q 2026E EBITDA estimates and consensus expectations and 2) Lower Macau gross gaming revenue (GGR) visibility in a prolonged period of heightened promotions. GGR forecasting impairment is driven by China macro, new tax on offshore trust assets, and State Council Order No. 841, which may slightly increase immigration scrutiny on intermediaries. Despite our rating change, we

Texas Capital Securities Downgrades Melco Resorts (MLCO) to Hold

Fri, 16 Oct 2026 04:31:12 -0400

Texas Capital Securities analyst David Bain downgraded Melco Resorts (NASDAQ: MLCO) from Buy to Hold with a price target of $5.50 (from $8.00).

Macau gaming revenue tracks below expectations in October

Mon, 12 Oct 2026 08:38:15 -0400

Investing.com -- Macau's gaming revenue in October is tracking toward a 6% to 10% year-over-year decline, falling short of market expectations for roughly flat growth, according to checks by Jefferies.

The projection comes against a challenging comparison of 16% growth in the same period last year. Market estimates on Bloomberg had anticipated flat year-over-year change for October 2026.

For the seven days ending on Saturday, Macau's gross gaming revenue averaged about MOP729 million per day, down 6% year-over-year but up 21% compared to September's average daily rate. Month-to-date mass and VIP gaming increased 35% to 38% and 40% to 45% month-over-month, respectively.

Industry

Macau gaming revenue tracks below expectations in October

Mon, 12 Oct 2026 08:38:15 -0400

The projection comes against a challenging comparison of 16% growth in the same period last year. Market estimates on Bloomberg had anticipated flat year-over-year change for October 2026.

Industry

Macau gaming revenue tracks below expectations in October

Mon, 12 Oct 2026 08:38:15 -0400

The projection comes against a challenging comparison of 16% growth in the same period last year. Market estimates on Bloomberg had anticipated flat year-over-year change for October 2026.

Industry

Macau gaming revenue tracks below expectations in October

Mon, 12 Oct 2026 08:38:15 -0400

The projection comes against a challenging comparison of 16% growth in the same period last year. Market estimates on Bloomberg had anticipated flat year-over-year change for October 2026.

Industry

Citi Starts Melco Resorts (MLCO) at Buy

Mon, 12 Oct 2026 05:02:56 -0400

Citi analyst Timothy Chau initiates coverage on Melco Resorts (NASDAQ: MLCO) with a Buy rating and a price target of $9.40.

For an analyst ratings summary and ratings history on Melco Resorts click here. For more ratings news on Melco Resorts click here.

Shares of Melco Resorts closed at $4.23 yesterday.

Citi Starts Melco Resorts (MLCO) at Buy

Mon, 12 Oct 2026 05:02:56 -0400

Citi analyst Timothy Chau initiates coverage on Melco Resorts (NASDAQ: MLCO) with a Buy rating and a price target of $9.40.

For an analyst ratings summary and ratings history on Melco Resorts click here. For more ratings news on Melco Resorts click here.

Shares of Melco Resorts closed at $4.23 yesterday.

Form SCHEDULE 13D/A Melco Resorts & Entertai Filed by: Melco International Development LTD

Fri, 09 Oct 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20261009/27168789.html

The More Life Company Advancing U.S. Compounded Pharmaceutical Commercialization Pathway for Quicksome™

Tue, 06 Oct 2026 08:45:00 -0400

Strategic LOI advances U.S. compounding capability for a growing portfolio of potential Quicksome-enabled pharmaceutical applications

TORONTO--(BUSINESS WIRE)-- The More Life Company Corp. (the “Company” or “MLCO”), (CSE: MLCO) (OTC: TMLCF) is pleased to announce that it has entered into a strategic letter of intent (“LOI”) with an established U.S. 503A compounding pharmacy to advance the development, compounding and commercialization of Quicksome™-enabled prescription compounded pharmaceutical products in the United States.

The contemplated relationship is designed to establish dedicated U.S. compounding capability for Quicksome, combining MLCO’s proprietary formulation and delivery technology with an experienced U.S. partner’s compounding, formulation development, pharmacy, dispensing,

The More Life Company Advancing U.S. Compounded Pharmaceutical Commercialization Pathway for Quicksome™

Tue, 06 Oct 2026 08:45:00 -0400

Strategic LOI advances U.S. compounding capability for a growing portfolio of potential Quicksome-enabled pharmaceutical applications

The More Life Company Advancing U.S. Compounded Pharmaceutical Commercialization Pathway for Quicksome™

Tue, 06 Oct 2026 08:45:00 -0400

Strategic LOI advances U.S. compounding capability for a growing portfolio of potential Quicksome-enabled pharmaceutical applications

The More Life Company Advancing U.S. Compounded Pharmaceutical Commercialization Pathway for Quicksome™

Tue, 06 Oct 2026 08:45:00 -0400

Strategic LOI advances U.S. compounding capability for a growing portfolio of potential Quicksome-enabled pharmaceutical applications

Form 144 Melco Resorts & Entertai Filed by: WINKLER EVAN ANDREW

Fri, 02 Oct 2026 06:30:00 -0400

si-local-file:///var/storage/secattach/20261002/27138670.html

Form 6-K Melco Resorts & Entertai For: Sep 23

Wed, 23 Sep 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260923/27097071.html

Melco’s Morpheus becomes Macau’s first hotel to receive Three MICHELIN Keys

Wed, 23 Sep 2026 04:31:00 -0400

MACAU, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment (NASDAQ: MLCO) announces that Morpheus at City of Dreams has been awarded Three MICHELIN Keys in the MICHELIN Guide’s 2026 global hotel selection, becoming the first hotel in Macau to receive the distinction. Morpheus was promoted from Two Keys, which it held in the 2025 selection.

Three MICHELIN Keys, described by the Guide as "an extraordinary stay", is the highest level of recognition in the MICHELIN Key system. The 2026 selection comprises 2,832 hotels worldwide, of which 155 hold Three Keys. Morpheus is one

Melco’s Morpheus becomes Macau’s first hotel to receive Three MICHELIN Keys

Wed, 23 Sep 2026 04:31:00 -0400

The More Life Company Reports Rapid Systemic Delivery of USP Testosterone in Exploratory Quicksome™ Study

Tue, 22 Sep 2026 08:50:00 -0400

Eight-participant pharmacokinetic study shows rapid systemic appearance following administration of 5 mg and 15 mg Quicksome™ sublingual formulations

TORONTO--(BUSINESS WIRE)-- The More Life Company Corp. (the “Company” or “MLCO”), (CSE: MLCO) (OTC: TMLCF), is pleased to announce results from an exploratory eight-participant human pharmacokinetic study conducted with third-party medical personnel to evaluate United States Pharmacopeia (“USP”) grade testosterone formulated using the Company’s patented Quicksome™ sublingual delivery technology.

The study showed rapid systemic appearance of USP testosterone following Quicksome administration, with substantial increases in measured serum testosterone observed within minutes of dosing. Peak serum testosterone concentrations were generally observed within

The More Life Company Reports Rapid Systemic Delivery of USP Testosterone in Exploratory Quicksome™ Study

Tue, 22 Sep 2026 08:50:00 -0400

Eight-participant pharmacokinetic study shows rapid systemic appearance following administration of 5 mg and 15 mg Quicksome™ sublingual formulations

The More Life Company Reports Rapid Systemic Delivery of USP Testosterone in Exploratory Quicksome™ Study

Tue, 22 Sep 2026 08:50:00 -0400

Eight-participant pharmacokinetic study shows rapid systemic appearance following administration of 5 mg and 15 mg Quicksome™ sublingual formulations

The More Life Company Reports Rapid Systemic Delivery of USP Testosterone in Exploratory Quicksome™ Study

Tue, 22 Sep 2026 08:50:00 -0400

Eight-participant pharmacokinetic study shows rapid systemic appearance following administration of 5 mg and 15 mg Quicksome™ sublingual formulations

Form SCHEDULE 13D/A Melco Resorts & Entertai Filed by: Melco International Development LTD

Fri, 18 Sep 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260918/27077838.html

Form 4 Melco Resorts & Entertai For: Sep 16 Filed by: HO LAWRENCE YAU LUNG

Fri, 18 Sep 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260918/27077812.html

The More Life Company Reports Positive Third-Party Agrarius Potato Trial Results in Brazil

Tue, 15 Sep 2026 08:50:00 -0400

Independent randomized field trial recorded numerical increases of up to 32.5% in special-grade potato yield and up to 27.6% in total yield in the leading Agrarius application programs

TORONTO--(BUSINESS WIRE)-- The More Life Company Corp. (the “Company” or “TMLC”) (CSE: MLCO) (OTCID: TMLCF) is pleased to report positive results from an independently conducted field trial evaluating the Company’s licensed Agrarius™ agricultural plant signaling technology in potato crops in Brazil.

The leading Agrarius application programs recorded numerical yield increases of up to 32.5% in special-grade potatoes and up to 27.6% in total potato yield compared with the control.

The study

The More Life Company Reports Positive Third-Party Agrarius Potato Trial Results in Brazil

Tue, 15 Sep 2026 08:50:00 -0400

Independent randomized field trial recorded numerical increases of up to 32.5% in special-grade potato yield and up to 27.6% in total yield in the leading Agrarius application programs

The leading Agrarius application programs recorded numerical yield increases of up to 32.5% in special-grade potatoes and up to 27.6% in total potato yield compared with the control.

The study